BioSpace News Archive

The Public Health Agency of Canada continues to monitor COVID-19 epidemiological indicators to quickly detect, understand and communicate emerging issues of concern.

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a presentation during the World Vaccine Congress Europe 2021.

Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), today announced an abstract on clinical data from the Company’s PHYOX™2 trial of nedosiran, an investigational GalXC™ RNAi candidate for the treatment of primary hyperoxaluria (PH), has been accepted as a late-breaker poster presentation at the American Society of Nephrology (ASN) Kidney Week 2021 taking place Nov. 4-7, 2021.

Trane Technologies (NYSE: TT), a global climate innovator, has completed the acquisition of Farrar Scientific, which the company announced in a press release on September 13, 2021.

Boehringer Ingelheim announced the U.S. Food and Drug Administration approved the supplemental Biologics License Application for Cyltezo® as the first Interchangeable biosimilar with Humira®.